A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

American Journal of Psychiatry

Volumn 158, Issue 2, 2001, Pages 282-288

  Wilens, T E ^a   Spencer, T J ^a   Biederman, J ^a   Girard, K ^a   Doyle, R ^a   Prince, J ^a   Polisher, D ^a   Solhkhah, R ^a   Comeau, S ^a   Monuteaux, M C ^a   Parekh, A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BUPROPION; COMORBIDITY; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PLACEBOS; TREATMENT OUTCOME;

EID: 0035140671     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.2.282     Document Type: Article

References (54)

1. Attention deficit hyperactivity disorder in adults
2. Adults with attention-deficit/hyperactivity disorder: A controversial diagnosis
3. Psychiatric status of hyperactives as adults: A controlled prospective 15-year followup of 63 hyperactive children
4. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder
5. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state
6. Attention-deficit hyperactivity disorder and substance abuse: Relationships and implications for treatment
7. Are attention-deficit hyperactivity disorder and the psychoactive substance use disorders really related?
8. Attention deficit hyperactivity disorder in childhood among adults with major depression
9. Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status
10. Predictors of persistence and remission of ADHD into adolescence: Results from a four-year prospective follow-up study
11. Persistence of ADHD into adulthood: It depends on whom you ask
12. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: Implications for clinical diagnosis
13. Pharmacotherapy of attention deficit hyperactivity disorder in adults
14. The stimulants revisited
15. Stimulant medications and the treatment of children with ADHD
16. Pharmacotherapy of attention-deficit disorder across the life cycle
17. Pemoline in attention deficit disorder and alcoholism: A case study
18. Bupropion: A review of its mechanism of antidepressant activity
19. A double-blind trial of bupropion in children with attention deficit disorder
20. Bupropion hydrochloride in attention deficit disorder with hyperactivity
21. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder
22. Bupropion treatment of attention-deficit hyperactivity disorder in adults
23. Psychiatric interviews suitable for use in research with children and adolescents
24. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder
25. Six-week, double-blind, placebo-controlled study of desipramine for adult attention-deficit hyperactivity disorder
26. CGI (Clinical Global Impression) scale
27. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder
28. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder
29. Towards a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder
30. Preliminary normative data on DSM-IV criteria for adults
31. A rating scale for depression
32. An inventory for measuring depression
33. The assessment of anxiety states by rating
34. Some conceptual and statistical issues in analysis of longitudinal psychiatric data
35. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder
36. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder
37. Effectiveness and tolerability of Adderall for adults with ADHD
38. The neurobiology of attention-deficit/hyperactivity disorder
39. Nicotinic systems and cognitive function
40. Cholinergic mediation of the inhibitory effect of methylphenidate on neuronal activity in the recticular formation
41. 4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder
42. 4 gene 7-repeat allele and attention deficit hyperactivity disorder
43. 4 receptor variants
44. Venlafaxine in adults with attention-deficit/hyperactivity disorder: An open clinical trial
45. The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder
46. Psychometric characteristics of the Wender Utah Rating Scale: Reliability and factor structure for men and women
47. Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder
48. Antidepressant-associated mania: A controlled comparison with spontaneous mania